The stable gastric pentadecapeptide BPC 157 has shown beneficial effects in several organ systems. This review specifically explores its effects on the central nervous system, with a focus on recent studies investigating its therapeutic potential in stroke, schizophrenia, and spinal cord injury. BPC 157’s stability and oral bioavailability make it an attractive candidate for CNS therapy.
You can find the full article HERE.



